COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST
Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed. L'invention conce...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | OSTOVICAZEN KARABORNI, SAMI LIU, JIWEN |
| description | Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed.
L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3192887A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3192887A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3192887A13</originalsourceid><addsrcrecordid>eNrjZDBy9ncOigwOcfQJVvB3U3D0U3B0cfXzD_b0c1VwNHJSCHJ1dg0I8Q8CyoQ4uvv7eQaH8DCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeGdHY0NLIwsLc0dDYyKUAAAawyY9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST</title><source>esp@cenet</source><creator>OSTOVICAZEN ; KARABORNI, SAMI ; LIU, JIWEN</creator><creatorcontrib>OSTOVICAZEN ; KARABORNI, SAMI ; LIU, JIWEN</creatorcontrib><description>Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed.
L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&CC=CA&NR=3192887A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25565,76548</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&CC=CA&NR=3192887A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OSTOVICAZEN</creatorcontrib><creatorcontrib>KARABORNI, SAMI</creatorcontrib><creatorcontrib>LIU, JIWEN</creatorcontrib><title>COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST</title><description>Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed.
L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBy9ncOigwOcfQJVvB3U3D0U3B0cfXzD_b0c1VwNHJSCHJ1dg0I8Q8CyoQ4uvv7eQaH8DCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeGdHY0NLIwsLc0dDYyKUAAAawyY9</recordid><startdate>20220310</startdate><enddate>20220310</enddate><creator>OSTOVICAZEN</creator><creator>KARABORNI, SAMI</creator><creator>LIU, JIWEN</creator><scope>EVB</scope></search><sort><creationdate>20220310</creationdate><title>COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST</title><author>OSTOVICAZEN ; KARABORNI, SAMI ; LIU, JIWEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3192887A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OSTOVICAZEN</creatorcontrib><creatorcontrib>KARABORNI, SAMI</creatorcontrib><creatorcontrib>LIU, JIWEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OSTOVICAZEN</au><au>KARABORNI, SAMI</au><au>LIU, JIWEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST</title><date>2022-03-10</date><risdate>2022</risdate><abstract>Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed.
L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3192887A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A16%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OSTOVICAZEN&rft.date=2022-03-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3192887A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |